The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses
Frontiers in Pharmacology
by
4d ago
..read more
Visit website
Editorial: Recent advances in cardiotoxicity testing, volume II
Frontiers in Pharmacology
by
4d ago
..read more
Visit website
A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine
Frontiers in Pharmacology
by
4d ago
..read more
Visit website
Active metabolites combination therapies: towards the next paradigm for more efficient and more scientific Chinese medicine
Frontiers in Pharmacology
by
2w ago
..read more
Visit website
Left Bundle Branch Pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes
Frontiers in Pharmacology
by
3w ago
..read more
Visit website
Cacao consumption improves passive avoidance memory impairment in a rat model of Alzheimer's disease: The role of hippocampal synaptic plasticity and oxidative stress
Frontiers in Pharmacology
by
3w ago
..read more
Visit website
Researchon the signaling pathway and the related mechanism of traditional Chinese medicine intervention in chronic gastritis of the "inflammation-cancer transformation"
Frontiers in Pharmacology
by
3w ago
..read more
Visit website
Publishing fees
Frontiers in Pharmacology
by
1M ago
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review ..read more
Visit website
Peer review
Frontiers in Pharmacology
by
1M ago
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days ..read more
Visit website
Author guidelines
Frontiers in Pharmacology
by
1M ago
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript ..read more
Visit website

Follow Frontiers in Pharmacology on FeedSpot

Continue with Google
Continue with Apple
OR